Search Results - "Tsuruta, Kozo"
-
1
Adult T-cell Leukemia/Lymphoma with Gastrointestinal Involvement
Published in Internal Medicine (01-07-2021)Get full text
Journal Article -
2
Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis
Published in Gut and liver (15-01-2022)“…Proteinase 3 antineutrophil cytoplasmic antibody (PR3-ANCA) is a serologic marker for granulomatosis with polyangiitis. However, recent studies have also shown…”
Get full text
Journal Article -
3
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
Published in Mediators of inflammation (2021)“…Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are…”
Get full text
Journal Article -
4
Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19
Published in Journal of clinical medicine (11-11-2020)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global coronavirus disease 2019 (COVID-19) outbreak. Along with the…”
Get full text
Journal Article -
5
Altered serum profile of the interleukin-22 system in inflammatory bowel disease
Published in Cytokine (Philadelphia, Pa.) (01-12-2020)“…•Serum IL-22 was lower in patients with inflammatory bowel disease than in controls.•The decrease in IL-22 was more dramatic in Crohn’s disease than ulcerative…”
Get full text
Journal Article -
6
Safety and efficacy of single‐needle leukocyte apheresis for treatment of ulcerative colitis
Published in Therapeutic apheresis and dialysis (01-10-2020)“…Leukocyte apheresis (LCAP) is a safe and effective treatment for active ulcerative colitis (UC) in Japan. Nevertheless, a limitation of LCAP is its requirement…”
Get full text
Journal Article -
7
Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease
Published in Kurume medical journal (31-12-2019)“…Fecal calprotectin has been proposed as a useful biomarker of disease activity in inflammatory bowel disease (IBD). However, the role of calprotectin in…”
Get more information
Journal Article -
8
Gene Expression of Transient Receptor Potential Channels in Peripheral Blood Mononuclear Cells of Inflammatory Bowel Disease Patients
Published in Journal of clinical medicine (14-08-2020)“…We examined the expression profile of transient receptor potential (TRP) channels in peripheral blood mononuclear cells (PBMCs) from patients with inflammatory…”
Get full text
Journal Article -
9
Adult T-cell Leukemia/Lymphoma with Gastrointestinal Involvement
Published in Internal Medicine (2021)Get full text
Journal Article -
10
Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
Published in Alimentary pharmacology & therapeutics (01-06-2024)“…Summary Background and Aims While filgotinib, an oral Janus kinase (JAK) 1 preferential inhibitor, is approved for moderately to severely active ulcerative…”
Get full text
Journal Article -
11
Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease
Published in Journal of Crohn's and colitis (25-09-2021)“…Abstract Background and Aims The Self-assembling Peptide Hydrogel [SAPH, PuraMatrix], a fully synthetic peptide solution designed to replace collagen, has…”
Get full text
Journal Article -
12
Utility of Diagnostic Colonoscopy in Pediatric Intestinal Disease
Published in Journal of clinical medicine (28-09-2022)“…Background: The roles and methods of diagnostic colonoscopy in pediatric patients were previously demonstrated. With advances in medical equipment and the…”
Get full text
Journal Article -
13
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan
Published in Alimentary pharmacology & therapeutics (22-11-2024)“…Three Janus kinase (JAK) inhibitors are approved for ulcerative colitis (UC) in Japan.BACKGROUNDThree Janus kinase (JAK) inhibitors are approved for ulcerative…”
Get full text
Journal Article